Search

Your search keyword '"Badawy, Sherif M."' showing total 193 results

Search Constraints

Start Over You searched for: Author "Badawy, Sherif M." Remove constraint Author: "Badawy, Sherif M." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years Language english Remove constraint Language: english
193 results on '"Badawy, Sherif M."'

Search Results

4. Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with non-malignant disorders: a retrospective cohort study

6. Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

8. Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities

9. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

10. Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients

12. A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease

13. Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

14. Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis

17. Impact of second primary malignancy postautologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis

18. Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood Transplantation

19. Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation

22. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML

24. Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

25. Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis

26. Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients

29. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy

30. Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis

32. Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases

33. What is in a name: defining pediatric refractory ITP

34. Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.

35. Health‐related quality of life with standard and curative therapies in thalassemia: A narrative literature review.

37. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy

38. The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials

39. Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research

40. Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome

42. Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators.

43. Boosting Hot Mix Asphalt Dynamic Modulus Prediction Using Statistical and Machine Learning Regression Modeling Techniques.

45. Practical Guidance for the Use of Voxelotor in the Management of Sickle Cell Disease

46. Evaluation of Waste Bottle Crates in the Form of Pyro-Oil and Fine Granules as Bitumen Rejuvenators and Modifiers.

47. Optimizing Shared Decision Making about Hydroxyurea in Young Children with Sickle Cell Anemia

48. Standardizing the Diagnostic and Therapeutic Approach to Newly Diagnosed Children with ITP: Prospective Data from the ITP Consortium of North America (ICON) Quality Improvement Initiative

49. Accuracy of online medical information: the case of social media in sickle cell disease.

Catalog

Books, media, physical & digital resources